These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 30578087)

  • 1. The value of tailoring vial sizes to populations and locations.
    Wedlock PT; Mitgang EA; Haidari LA; Prosser W; Brown ST; Krudwig K; Siegmund SS; DePasse JV; Bakal J; Leonard J; Welling J; Steinglass R; Mwansa FD; Phiri G; Lee BY
    Vaccine; 2019 Jan; 37(4):637-644. PubMed ID: 30578087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-chamber injection device for measles-rubella vaccine: The potential impact of introducing varying sizes of the devices in 3 countries.
    Wedlock PT; Mitgang EA; Siegmund SS; DePasse J; Bakal J; Leonard J; Welling J; Brown ST; Lee BY
    Vaccine; 2018 Sep; 36(39):5879-5885. PubMed ID: 30146404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the economic impact of different vial-opening thresholds for measles-containing vaccines.
    Wedlock PT; Mitgang EA; Oron AP; Hagedorn BL; Leonard J; Brown ST; Bakal J; Siegmund SS; Lee BY
    Vaccine; 2019 Apr; 37(17):2356-2368. PubMed ID: 30914223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in Zambia.
    Krudwig K; Knittel B; Karim A; Kanagat N; Prosser W; Phiri G; Mwansa F; Steinglass R
    Vaccine; 2020 Aug; 38(37):5905-5913. PubMed ID: 32703746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One size does not fit all: The impact of primary vaccine container size on vaccine distribution and delivery.
    Haidari LA; Wahl B; Brown ST; Privor-Dumm L; Wallman-Stokes C; Gorham K; Connor DL; Wateska AR; Schreiber B; Dicko H; Jaillard P; Avella M; Lee BY
    Vaccine; 2015 Jun; 33(28):3242-7. PubMed ID: 25889160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine wastage in Nigeria: An assessment of wastage rates and related vaccinator knowledge, attitudes and practices.
    Wallace AS; Willis F; Nwaze E; Dieng B; Sipilanyambe N; Daniels D; Abanida E; Gasasira A; Mahmud M; Ryman TK
    Vaccine; 2017 Dec; 35(48 Pt B):6751-6758. PubMed ID: 29066189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining the optimal vaccine vial size in developing countries: a Monte Carlo simulation approach.
    Dhamodharan A; Proano RA
    Health Care Manag Sci; 2012 Sep; 15(3):188-96. PubMed ID: 22528136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model.
    Assi TM; Brown ST; Djibo A; Norman BA; Rajgopal J; Welling JS; Chen SI; Bailey RR; Kone S; Kenea H; Connor DL; Wateska AR; Jana A; Wisniewski SR; Van Panhuis WG; Burke DS; Lee BY
    BMC Public Health; 2011 Jun; 11():425. PubMed ID: 21635774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health Care Worker Preferences and Perspectives on Doses per Container for 2 Lyophilized Vaccines in Senegal, Vietnam, and Zambia.
    Kanagat N; Krudwig K; Wilkins KA; Kaweme S; Phiri G; Mwansa FD; Mvundura M; Robertson J; Kristensen D; Gueye A; Dao SD; Thai PQ; Nguyen HT; Tran TC
    Glob Health Sci Pract; 2020 Dec; 8(4):680-688. PubMed ID: 33361235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
    Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential effects of introducing microneedle patch vaccines into routine vaccine supply chains.
    Wedlock PT; Mitgang EA; Elsheikh F; Leonard J; Bakal J; Welling J; Crawford J; Assy E; Magadzire BP; Bechtel R; DePasse JV; Siegmund SS; Brown ST; Lee BY
    Vaccine; 2019 Jan; 37(4):645-651. PubMed ID: 30578088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine wastage in Ghana, Mozambique, and Pakistan: An assessment of wastage rates for four vaccines and the context, causes, drivers, and knowledge, attitudes and practices for vaccine wastage.
    Mvundura M; Ng J; Reynolds K; Theng Ng Y; Bawa J; Bambo M; Bonsu G; Payne J; Chua J; Guerette J; Odei Antwi-Agyei K; Ribe S; Chinavane D; Arhin-Wiredu K; Shah A; Sitoe J; Yunus S; Powelson J; Amponsa-Achiano K; Eshioramhe Kojak K; Fredick Dadzie J; Asghar N; Caetano Correa G; Robertson J
    Vaccine; 2023 Jun; 41(28):4158-4169. PubMed ID: 37270365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine wastage in The Gambia: a prospective observational study.
    Usuf E; Mackenzie G; Ceesay L; Sowe D; Kampmann B; Roca A
    BMC Public Health; 2018 Jul; 18(1):864. PubMed ID: 29996802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost saving opportunity of introducing a card review into measles-containing vaccination campaigns.
    Hagedorn BL; Dabbagh A; McCarthy KA
    Vaccine; 2019 Sep; 37(41):6093-6101. PubMed ID: 31471145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the costs of the vaccine supply chain and service delivery for selected districts in Kenya and Tanzania.
    Mvundura M; Lorenson K; Chweya A; Kigadye R; Bartholomew K; Makame M; Lennon TP; Mwangi S; Kirika L; Kamau P; Otieno A; Murunga P; Omurwa T; Dafrossa L; Kristensen D
    Vaccine; 2015 May; 33(23):2697-703. PubMed ID: 25865467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A microneedle patch for measles and rubella vaccination: a game changer for achieving elimination.
    Prausnitz MR; Goodson JL; Rota PA; Orenstein WA
    Curr Opin Virol; 2020 Apr; 41():68-76. PubMed ID: 32622318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of an Intervention to Use a Measles, Rubella, and Polio Mass Vaccination Campaign to Strengthen Routine Immunization Services in Nepal.
    Wallace AS; Bohara R; Stewart S; Subedi G; Anand A; Burnett E; Giri J; Shrestha J; Gurau S; Dixit S; Rajbhandari R; Schluter WW
    J Infect Dis; 2017 Jul; 216(suppl_1):S280-S286. PubMed ID: 28838201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of the wastage rate of MMR and pentavalent vaccines in open and closed vials in three western provinces of Iran.
    Zahraei SM; Zamani G; Mohammadbeigi A; Asgarian A; Afrashteh S; Gharibnavaz H; Haghgou M; Kone S
    Heliyon; 2020 May; 6(5):e04016. PubMed ID: 32462097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of vaccine wastage rates, missed opportunities, and related knowledge, attitudes and practices during introduction of a second dose of measles-containing vaccine into Cambodia's national immunization program.
    Wallace AS; Krey K; Hustedt J; Burnett E; Choun N; Daniels D; Watkins ML; Soeung SC; Duncan R
    Vaccine; 2018 Jul; 36(30):4517-4524. PubMed ID: 29907485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.